We identified several biomarkers with higher fold changes than TSP-1, and then tested all top hits using plasma samples from rGBM (n = 22) and pancreatic cancer (n = 17) patients using ELISA kits. This evidence concerns the gene THBS1 and familial pancreatic carcinoma.